CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2007-06-26): HCV seropositivity predisposes patients to end-stage renal disease

Clinical

HCV seropositivity predisposes patients to end-stage renal disease

Last Updated: 2007-06-26 11:17:13 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Adults seropositive for hepatitis C virus (HCV) are at increased risk for developing end-stage renal disease (ESRD), investigators in San Francisco report in the June 25th issue of the Archives of Internal Medicine.

The liver is not the only organ affected by HCV, Dr. Judith I. Tsui and her associates note. Even so, they say, the risk for clinically significant renal outcomes is not known.

Dr. Tsui, from the Veterans Affairs Medical Center, and her team linked data from Medicare, the Department of Veterans Affairs, and the United States Renal Data System. Their goal was to see if HCV infection was associated with treated ESRD, defined as hemodialysis or kidney transplantation.

Their study cohort included veterans who had undergone at least 1 serum creatinine measurement within the VA between October 2000 and September 2001. The analytic cohort included 474,000 who were tested for HCV within 1 year of the creatinine test, of whom 53,000 tested positive. Subjects were followed until October 2004.

Among those with an estimated glomerular filtration rate of at least 30 mL/min per 1.73 meter squared, the adjusted hazard rate was 2.80 for ESRD among those that were HCV-positive.

"The effect was only was only present in patients younger than 70 years and was stronger for patients with normal or somewhat preserved renal function," the authors report.

However, once ESRD became established, progression was more rapid among patients that were HCV-positive.

"Patients with HCV are more likely to experience rapid decline in renal function," the authors conclude.

Arch Intern Med 2007;167:1271-1276.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.